SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-21-000240
Filing Date
2021-05-06
Accepted
2021-05-06 17:27:19
Documents
6
Period of Report
2021-04-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT FOR 04-27-2021 form_8-k.htm 8-K 15932
2 PRESS RELEASE DATED APRIL 19, 2021 ex_99-1.htm EX-99 5463
3 PRESS RELEASE DATED APRIL 20, 2021 ex_99-2.htm EX-99 5437
4 PRESS RELEASE DATED APRIL 21, 2021 ex_99-3.htm EX-99 6552
5 PRESS RELEASE DATED MAY 4, 2021 ex_99-4.htm EX-99 8713
6 GRAPHIC angiosoma_logo.jpg GRAPHIC 10351
  Complete submission text file 0001161697-21-000240.txt   57776
Mailing Address 719 JADWIN AVENUE RICHLAND WA 99352
Business Address 719 JADWIN AVENUE RICHLAND WA 99352 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-55072 | Film No.: 21899095
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences